-
公开(公告)号:US20050197346A1
公开(公告)日:2005-09-08
申请号:US11015915
申请日:2004-12-17
IPC分类号: A61K31/496 , C07D211/58 , C07D277/64 , C07D417/02 , C07D417/12
CPC分类号: C07D211/58 , C07D277/64 , C07D417/12
摘要: Disclosed are novel substituted heterocyclic derivatives having the structure of Formula I: The compounds are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, diabetes, and myocardial infarction.
摘要翻译: 公开了具有式I结构的新型取代的杂环衍生物:该化合物可用于治疗各种疾病状态,特别是心血管疾病如心房和室性心律失常,间歇性跛行,Prinzmetal(变异)心绞痛,稳定和不稳定型心绞痛, 运动诱发心绞痛,充血性心脏病,糖尿病和心肌梗死。
-
公开(公告)号:US06930111B2
公开(公告)日:2005-08-16
申请号:US10198237
申请日:2002-07-18
申请人: Prabha Ibrahim , Kevin Shenk , Elfatih Elzein , Venkata Palle , Jeff Zablocki , Kenneth S. Rehder
发明人: Prabha Ibrahim , Kevin Shenk , Elfatih Elzein , Venkata Palle , Jeff Zablocki , Kenneth S. Rehder
IPC分类号: A61K31/4245 , A61K31/496 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/10 , A61P17/02 , A61P19/00 , A61P21/00 , A61P37/06 , A61P43/00 , C07D263/56 , C07D263/57 , C07D271/06 , C07D277/64 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , A61K31/497
CPC分类号: C07D263/57 , C07D271/06 , C07D277/64 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes, and for increasing HDL plasma levels in mammals.
摘要翻译: 公开了可用于治疗各种疾病状态,特别是心血管疾病如心房和室性心律失常,间歇性跛行,Prinzmetal(变体)心绞痛,稳定和不稳定型心绞痛,运动诱发的心绞痛,充血性心脏病和心肌的新型杂环衍生物 梗死。 该化合物还可用于治疗糖尿病,并且用于增加哺乳动物的HDL血浆水平。
-
公开(公告)号:US20050101778A1
公开(公告)日:2005-05-12
申请号:US10942582
申请日:2004-09-16
申请人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: A61P11/06 , C07D473/00 , C07D473/06 , C07D473/08 , A61K31/522 , C07D473/02
CPC分类号: C07D473/00 , C07D473/06 , C07D473/08
摘要: Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
-
公开(公告)号:US07655638B2
公开(公告)日:2010-02-02
申请号:US11600523
申请日:2006-11-15
CPC分类号: A61K31/7076 , C07D473/16 , C07H19/16
摘要: Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
摘要翻译: 公开了作为部分和全部A1腺苷受体激动剂的新型化合物,其可用于治疗各种疾病状态,特别是心动过速和心房扑动,心绞痛和心肌梗死。
-
公开(公告)号:US07452889B2
公开(公告)日:2008-11-18
申请号:US11845720
申请日:2007-08-27
申请人: Elfatih Elzein , Prabha Ibrahim , Venkata Palle , Kenneth Rehder , Jeff Zablocki
发明人: Elfatih Elzein , Prabha Ibrahim , Venkata Palle , Kenneth Rehder , Jeff Zablocki
IPC分类号: A61K31/496 , C07D417/12
CPC分类号: C07D211/58 , C07D277/64 , C07D417/12
摘要: Disclosed are novel substituted heterocyclic derivatives having the structure of Formula I: The compounds are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, diabetes, and myocardial infarction.
摘要翻译: 公开了具有式I结构的新型取代的杂环衍生物:该化合物可用于治疗各种疾病状态,特别是心血管疾病如心房和室性心律失常,间歇性跛行,Prinzmetal(变异)心绞痛,稳定和不稳定型心绞痛, 运动诱发心绞痛,充血性心脏病,糖尿病和心肌梗死。
-
公开(公告)号:US07304070B2
公开(公告)日:2007-12-04
申请号:US10942582
申请日:2004-09-16
申请人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: C07D473/06 , A61K31/522 , A61P25/28 , A61P11/06 , A61P25/16
CPC分类号: C07D473/00 , C07D473/06 , C07D473/08
摘要: Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
摘要翻译: 公开了具有式I或式II结构的新型A 2 B 2 N腺苷受体拮抗剂:
-
47.
公开(公告)号:US07109330B2
公开(公告)日:2006-09-19
申请号:US10794828
申请日:2004-03-03
申请人: Robert Lum , Cheri Lynn Blum , Richard Mackman , Michael Wick , Steven Schow , Jeff Zablocki , Prabha Ibrahim
发明人: Robert Lum , Cheri Lynn Blum , Richard Mackman , Michael Wick , Steven Schow , Jeff Zablocki , Prabha Ibrahim
IPC分类号: C07D473/16 , C07D473/40 , A61K31/53 , A61P35/00 , A61P3/10
CPC分类号: B60R1/00 , C07D473/16 , C07D473/40 , G08G1/163
摘要: Compounds of the following formula are provided: In the Formula (I), R1 is —X—R1′; in which R1′ is optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl, and X is —NH—. R2 is lower alkyl optionally substituted with one, two or three groups chosen from hydroxy, lower alkoxy, and halogen. And R3 is —NR4R5; in which R4 is hydrogen and R5 is lower alkyl substituted with amino; or (ii) R4 and R5 are both lower alkyl optionally substituted with one, two or three groups chosen from hydroxy and amino. It is to be understood that R1′ is not cyclohexylmethyl, phenyl, substituted phenyl, benzyl, phenylethyl, or m-hydroxybenzyl. The compounds inhibit CDK-2 activity and are useful for treating disorders characterized by undesirable cell proliferation.
摘要翻译: 提供下式的化合物:在式(I)中,R 1是-X-R 1'; 其中R 1'是任选取代的低级烷基,任选取代的芳基,任选取代的杂芳基或任选取代的杂环基,X是-NH-。 R 2是任选被一个,两个或三个选自羟基,低级烷氧基和卤素的基团取代的低级烷基。 并且R 3是-NR 4 R 5; 其中R 4是氢,R 5是被氨基取代的低级烷基; 或(ii)R 4和R 5均为任选被一个,两个或三个选自羟基和氨基的基团取代的低级烷基。 应当理解,R 1不是环己基甲基,苯基,取代的苯基,苄基,苯乙基或间羟基苄基。 该化合物抑制CDK-2活性,并且可用于治疗以不期望的细胞增殖为特征的疾病。
-
公开(公告)号:US07026321B2
公开(公告)日:2006-04-11
申请号:US10759555
申请日:2004-01-16
申请人: Robert Jiang , Tim Marquart , Jeff Zablocki , Elfatih Elzein , Venkata Palle , Prabha Ibrahim
发明人: Robert Jiang , Tim Marquart , Jeff Zablocki , Elfatih Elzein , Venkata Palle , Prabha Ibrahim
IPC分类号: A61K31/44
CPC分类号: C07D417/12 , C07D277/64
摘要: Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
摘要翻译: 公开了可用于治疗各种疾病状态,特别是心血管疾病如心房和室性心律失常,间歇性跛行,Prinzmetal(变体)心绞痛,稳定和不稳定型心绞痛,运动诱发的心绞痛,充血性心脏病和心肌的新型杂环衍生物 梗死。 该化合物也可用于治疗糖尿病。
-
公开(公告)号:US06977300B2
公开(公告)日:2005-12-20
申请号:US10431167
申请日:2003-05-06
申请人: Rao Kalla , Thao Perry , Elfaith Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfaith Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: A61P11/06 , C07D473/00 , C07D473/06 , C07D473/08 , C07D473/04 , A61K31/522 , A61P25/16 , A61P35/00
CPC分类号: C07D473/00 , C07D473/06 , C07D473/08
摘要: Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
摘要翻译: 公开了具有式I或式II结构的新的Aβ2 N 2腺苷受体拮抗剂:该化合物特别可用于治疗哮喘,炎症性胃肠道疾病,心血管疾病,神经障碍以及与不良反应有关的疾病 血管生成。
-
公开(公告)号:US20050038045A1
公开(公告)日:2005-02-17
申请号:US10947708
申请日:2004-09-23
申请人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: C07D473/04 , A61K31/522 , A61K31/53 , A61P1/12 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/06 , A61P25/16 , A61P25/28 , A61P27/02 , A61P35/00 , A61P43/00 , C07D285/08 , C07D473/00 , C07D473/06 , C07D473/08
CPC分类号: C07D473/00 , C07D473/06 , C07D473/08
摘要: Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
摘要翻译: 公开了作为A2B腺苷受体拮抗剂的新型化合物,其可用于治疗各种疾病状态,包括哮喘和腹泻。
-
-
-
-
-
-
-
-
-